78 related articles for article (PubMed ID: 9815662)
1. Prognostic factors in clinical cancer trials.
Estey E
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2591-3. PubMed ID: 9815662
[TBL] [Abstract][Full Text] [Related]
2. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.
Royston P; Sauerbrei W
Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of long-term survival: use of diagnostics and robust estimators with Cox's proportional hazards model.
Valsecchi MG; Silvestri D; Sasieni P
Stat Med; 1996 Dec; 15(24):2763-80. PubMed ID: 8981685
[TBL] [Abstract][Full Text] [Related]
4. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ
J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201
[TBL] [Abstract][Full Text] [Related]
5. A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis.
Faraggi D; Simon R
Stat Med; 1996 Oct; 15(20):2203-13. PubMed ID: 8910964
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
Argiris A; Li Y; Forastiere A
Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
[TBL] [Abstract][Full Text] [Related]
7. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
8. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
[TBL] [Abstract][Full Text] [Related]
9. Methods for categorizing a prognostic variable in a multivariable setting.
Mazumdar M; Smith A; Bacik J
Stat Med; 2003 Feb; 22(4):559-71. PubMed ID: 12590414
[TBL] [Abstract][Full Text] [Related]
10. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.
Mayers C; Panzarella T; Tannock IF
Cancer; 2001 Jun; 91(12):2246-57. PubMed ID: 11413512
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
Hernández AV; Eijkemans MJ; Steyerberg EW
Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
[TBL] [Abstract][Full Text] [Related]
15. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
17. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
Yamamoto N; Tamura T; Fukuoka M; Saijo N
Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
[TBL] [Abstract][Full Text] [Related]
18. The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.
Renzulli P; Lowy A; Maibach R; Egeli RA; Metzger U; Laffer UT
Surgery; 2006 Mar; 139(3):296-304. PubMed ID: 16546492
[TBL] [Abstract][Full Text] [Related]
19. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
Motzer RJ; Bacik J; Schwartz LH; Reuter V; Russo P; Marion S; Mazumdar M
J Clin Oncol; 2004 Feb; 22(3):454-63. PubMed ID: 14752067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]